FDA Approval, page-26

Thanks that was my understanding, interestingly bioshares (they have a model portfolio) sold their LBT holding last year but LBT still subscribe.

Will be interesting to see when they buy back in.

As I said I don't subscribe and don't know numbers on private subscriptions but corporate subscribers are as follows:

Corporate Subscribers: Cogstate, Bionomics, Impedimed, LBT Innovations, Tissue Therapies, Viralytics, Phylogica, pSivida, Benitec BioPharma, Invion, Imugene, Analytica, Circadian Technologies, Reproductive Health Science, Regeneus, Innate Immunotherapeutics, Anatara Life Sciences, ResApp, Pharmaxis, Starpharma, Antisense Therapeutics, Atcor Medical